Telmisartan Impurity 38 | CAS 2326298-47-7 - Request Quote
Telmisartan Impurity 38
| SZ CAT No: | SZ-T006074 |
| CAS No | 2326298-47-7 |
| Mol.F. | C12H16N2O2 |
| Mol.Wt. | 220.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Telmisartan Impurity 38 is chemically 4-Butyrimidamido-3-methylbenzoic acid. Telmisartan Impurity 38 is supplied with detailed characterization data compliant with regulatory guideline. Telmisartan Impurity 38 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Telmisartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2326298-47-7
Purchase 2326298-47-7
Order 2326298-47-7
Enquire 2326298-47-7
price of 2326298-47-7
2326298-47-7 Supplier
2326298-47-7 Manufacturer
2326298-47-7 Exporter
buy high quality Telmisartan Impurity 38
Purchase Telmisartan Impurity 38
Telmisartan Impurity 38 suppliers
Telmisartan Impurity 38 manufacturers
Telmisartan Impurity 38 price
Order Telmisartan Impurity 38
Enquire Telmisartan Impurity 38
Telmisartan Impurity 38 cost
Telmisartan Impurity 38 Supplier
Telmisartan Impurity 38 Distributor
Telmisartan Impurity 38 for Method Validation
Telmisartan Reference Standard
Telmisartan Impurity 38 for ANDA Filing
Telmisartan Impurity 38 for Forced Degradation Studies
Telmisartan Impurity 38 Identification Standards
Telmisartan Impurity 38 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.